Allspring Global Investments Holdings, LLC Avidity Biosciences, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.3 Billion
Q4 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$37.21 - $48.14 $24,446 - $31,627	657 New	657 $30,000
Q4 2022 Jan 23, 2023	SELL	$10.06 - $22.66 $231 - $521	-23 Reduced 2.16%	1,041 $0
Q3 2022 Oct 26, 2022	SELL	$15.46 - $23.43 $8,719 - $13,214	-564 Reduced 34.64%	1,064 $17,000
Q1 2022 May 02, 2022	BUY	$14.2 - $23.78 $23,117 - $38,713	1,628 New	1,628 $30,000

Others Institutions Holding RNA

# of Institutions

250

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

Price T Rowe Associates Inc Baltimore, MD

10.6M
Shares

$365 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

9.43M
Shares

$324 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.62M
Shares

$296 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

8.13M
Shares

$279 Million
5.95% of portfolio
Wellington Management Group LLP Boston, MA

7.03M
Shares

$241 Million
0.06% of portfolio

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.79B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account